Medics autonomously stopping hermorrhage (mash)
Active Other Transaction Agreement Awarded Last action
- Contract number
- HR0011269E134
- Awardee
-
Sri International UEI SRG2J1WS9X63
- Awarding agency
-
Defense Advanced Research Projects Agency
Department of Defense
- Obligated
- $5,441,896
Award facts
- Contract value 39% obligated
-
- $8,435,398.00 Current, with exercised options
- $14,133,417.00 Potential, with all options
- Completion date 21% complete
- Current and potential, with all options
- NAICS code
- Not on record
- Competition
- Competed Program Solicitation
- Pricing
- Other
- Place of performance
- Menlo Park, CA 94025, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $5,441,896 |
About this award
The Defense Advanced Research Projects Agency awarded an Other Transaction Agreement to Sri International for the Medics Autonomously Stopping Hemorrhage (MASH) program with a ceiling value of $14,133,417, effective as of the award date of May 19, 2026. The OTA sits outside the Federal Acquisition Regulation and operates under DARPA's authority to conduct prototype, R&D, and advanced technology development efforts.
Performance extends through May 18, 2028 and is based in Menlo Park, California. The agreement funds development of autonomous hemorrhage-control technologies, a capability area aligned with Sri International's existing portfolio in autonomous systems research and advanced biomedical sensor development. Sri International is a non-profit research and development organization and competes as a prime contractor on the vast majority of its federal awards. The organization operates across defense and civilian health research domains and maintains multiple standing research vehicles with DARPA covering artificial intelligence, photonic interfaces, and emerging computational methodologies, alongside substantial portfolios with the National Institutes of Health, particularly the National Institute of Allergy and Infectious Diseases and the National Institute on Drug Abuse, in drug development and biomedical research services.
Quick answers
Who was awarded contract HR0011269E134?
HR0011269E134 was awarded to Sri International by Defense Advanced Research Projects Agency (Department of Defense) on May 19, 2026.
How much is contract HR0011269E134 worth?
The government has obligated $5,441,896 on HR0011269E134. Its current value, with exercised options, is $8,435,398. Its potential value, with all options, is $14,133,417.
Was contract HR0011269E134 competed?
The extent of competition for HR0011269E134 was competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award